In Israel in 1964 the most prominent compound in Cannabis sativa L., a non-toxic herb commonly referred to simply as 'Cannabis', delta-9-Tetrahydrocannabinol (THC), was discovered. THC starts out in the Cannabis plant as geranyl pyrophosphate and olivetolic acid. Through enzyme catalisation (an increase in the rate of chemical reaction, without which most biochemical reactions would not occur) they become Cannabigerolic acid (CBG-a), the essential precursor for all cannabinoids. CBG-a becomes THC-a, a cannabinoid which has very different effects to THC. But, with heat or over time, THC-a decarboxylates into THC. Cannabinoids are specialised molecules that mimic similar chemicals in the human body and fit into special receptors within the brain, nervous and immune systems and as reported in the scientific literature at this time there are around 111 known natural cannabinoids.

Cannabinoids have been found to work synergistically with the human body and, more specifically, the Endogenous Cannabinoid System (ECS). The human body produces its own cannabinoids, called endocannabinoids (endogenous means produced internally). Phytocannabinoids (literally, 'plant' cannabinoids) from the Cannabis plant are a perfect fit for the specialised cannabinoid receptors found throughout the brain, nervous and immune systems. In addition, cannabinoids do more than work independently to deliver a particular therapeutic effect, they also work in tandem to regulate one another, something that has been labelled the Entourage Effect. These miracle molecules give the herb a wide variety of therapeutic benefits, from reducing inflammation to managing pain and many researchers and patients have begun to recognise the fact that single cannabinoid extracts may not be the best solution for the majority of patients.


The commercial value in most jurisdictions where use of Cannabis is still illegal is typically dictated by the amount of THC it contains. Cannabis strains with larger percentages of THC (12-21% is purportedly the average) are capable of delivering more potent therapeutic and medicinal efficacy. Some strains of Cannabis, such as Train Wreck and OG Kush, feature THC in quantities as high as 24-30%. Concentrates, such as hash and wax may feature as much as 85% THC. One method of isolating the THC contained in whole plant Cannabis is to vaporise it, allowing it to be consumed without the tars and toxins of smoking.
Regulation of THC by other cannabinoids like CBG also affect potency and overall effect, providing another buffer. A 2009 study revealed that using only 10 times the “effective” dose of alcohol can be fatal, whereas 1,000 times the effective amount would be necessary to achieve a fatal dose of Cannabis, a quantity impossible to consume! More research has indicated additional reasons why humans don’t die from Cannabis poisoning. In 2014, the journal Science published results from a French study, Pregnenolone Can Protect the Brain from Cannabis Intoxication, which documented the discovery and presence of a natural hormone that reverses Cannabis intoxication - in rats, at least. According to the researchers: “When the [rat] brain is stimulated by high doses of THC, it produces pregnenolone - a 3,000% increase - that inhibits the effects of THC”.
Therapeutic and medicinal values include (but are certainly not limited to):
Synthetic THC has been available in pill form and used for treating nausea and vomiting in cancer patients since the 1980's. In the US, a growing number of cancer patients and oncologists view Cannabis as a viable alternative for managing chemotherapy’s effects, as well as some of the physical and emotional health consequences of cancer, such as bone pain, anxiety and depression. Marinol® was the first synthetic THC pharmaceutical to be approved by the US Food and Drug Administration (FDA) for this purpose. Since then, other THC pills have been developed and prescribed to patients undergoing chemotherapy. However, the danger with synthesising any plant extract is that you lose the intrinsic checks and balances provided by nature and undesirable side-effects ensue. For example, Marinol® causes more psychoactive effects than natural, organic THC! Nature is always best, even when the pharmaceutical industry tries to tell us otherwise!
♋ Glaucoma – Glaucoma causes patients to develop a reduced field of vision that can lead to blindness. Glaucoma is incurable and the second leading cause of blindness in the world, according to the World Health Organization. There are actually several different types of Glaucoma, but only two are common. These two are characterised by an increase in intraocular pressure (IOP), or pressure inside the eye (shown in the diagram), which damages the optic nerve. The cause of the increase in eye pressure is similar, but different between the two most common types. A benefit of THC, recognised early on, was its potential to relieve eye pressure in patients with glaucoma. Studies in the 1970's showed that smoking Cannabis could reduce symptoms in Glaucoma sufferers and scientists tried (and failed) to develop a way to administer THC in eye drops. The idea proved too complicated due to THC not being soluble in water. In 2004 in an article titled "Glaucoma", by GW Pharmaceuticals Cannabinoid Research Institute stated; "The ability of Cannabis and THC to lower intra-ocular pressure in Glaucoma was serendipitously discovered in the late 1970's by a variety of patients and researchers. Several patients in the US Compassionate Use Investigational New Drug Program maintained their vision while employing large amounts of daily Cannabis in situations where standard drug therapy failed ... An emerging concept is that Glaucoma represents a progressive vascular retinopathy that requires a neuroprotectant to preserve vision. Some of the resulting optic nerve damage accrues due to NMDA hyperexcitability, an effect that THC and CBD may counter as neuroprotective antioxidants. Thus, Glaucoma is an area where Cannabis and cannabinoids may offer particular advantages over available single ingredient ocular anti-hypertensive agents".
♋ HIV/AIDS (Acquired Immunodeficiency Syndrome) – The American Academy of HIV Medicine (AAHIVM) stated in 2007, "When appropriately prescribed and monitored, Cannabis can provide immeasurable benefits for the health and well-being of our patients". Also in 2007, Dr Donald Abrams, Professor of Clinical Medicine (University of California, San Francisco) wrote an article; Cannabis in Painful HIV-Associated Sensory Neuropathy: A Randomized Placebo-Controlled Trial, in the journal Neurology: "Objective: To determine the effect of smoked Cannabis on the neuropathic pain of HIV-associated sensory neuropathy, and an experimental pain model ... Patients were randomly assigned to smoke either cannabis (3.56% THC) or identical placebo cigarettes with the cannabinoids extracted three times daily for 5 days ... Conclusion: Smoked Cannabis was well tolerated and effectively relieved chronic neuropathic pain from HIV-associated sensory neuropathy. The findings are comparable to oral drugs used for chronic neuropathic pain". A group of researchers from Louisiana State University (US) published a study in 2014 in the journal AIDS Research and Human Retroviruses which suggests Cannabis can help stop the progression of HIV/AIDS and its associated symptoms of chronic pain, nausea, fatigue and more. The specific compound that halts the spread of HIV compounds into other healthy cells is none other than THC.
♋ HIV/AIDS (Acquired Immunodeficiency Syndrome) – The American Academy of HIV Medicine (AAHIVM) stated in 2007, "When appropriately prescribed and monitored, Cannabis can provide immeasurable benefits for the health and well-being of our patients". Also in 2007, Dr Donald Abrams, Professor of Clinical Medicine (University of California, San Francisco) wrote an article; Cannabis in Painful HIV-Associated Sensory Neuropathy: A Randomized Placebo-Controlled Trial, in the journal Neurology: "Objective: To determine the effect of smoked Cannabis on the neuropathic pain of HIV-associated sensory neuropathy, and an experimental pain model ... Patients were randomly assigned to smoke either cannabis (3.56% THC) or identical placebo cigarettes with the cannabinoids extracted three times daily for 5 days ... Conclusion: Smoked Cannabis was well tolerated and effectively relieved chronic neuropathic pain from HIV-associated sensory neuropathy. The findings are comparable to oral drugs used for chronic neuropathic pain". A group of researchers from Louisiana State University (US) published a study in 2014 in the journal AIDS Research and Human Retroviruses which suggests Cannabis can help stop the progression of HIV/AIDS and its associated symptoms of chronic pain, nausea, fatigue and more. The specific compound that halts the spread of HIV compounds into other healthy cells is none other than THC.
♋ Post Traumatic Stress Disorder (PTSD) - The euphoric 'high' from THC is associated with temporary impairment of memory. While this may be seen as a drawback for some Cannabis users, impaired memory is often therapeutic for those who struggle to forget painful memories, such as patients who suffer from PTSD. In 2014, research out of Israel confirmed oral doses of THC can help relieve a variety of PTSD-related symptoms including flashbacks, agitation and nightmares. In a 3-week pilot study involving 10 patients with severe PTSD, oral doses of THC led to significant improvement across a number of measures, including sleep and hyperarousal symptoms. The findings were published in the journal Clinical Drug Investigation. The researchers wrote, “The results show good tolerance and safety, reduction of PTSD hyperarousal symptoms, improved sleep quality and reduced frequency of nightmares”. Recent evidence suggests cannabinoids may enhance the ability to overcome traumatic memories. What’s more, cannabinoids are known to affect sleep in various ways, including a decrease in REM sleep — the sleep phase during which nightmares occur. Anecdotal reports also suggest Cannabis may be of benefit. Also in 2014, psychometric data on PTSD symptoms collected during 80 psychiatric evaluations of patients applying to the New Mexico (US) Medical Cannabis Program between 2009-20011 was statistically analysed. PTSD symptoms were reduced by more than 75% in patients using Cannabis ...". The 2015 study, Use and effects of cannabinoids in military veterans with Post Traumatic Stress Disorder, concluded; "evidence indicates that substantial numbers of military veterans with PTSD use Cannabis or derivative products to control PTSD symptoms, with some patients reporting benefits in terms of reduced anxiety and insomnia and improved coping ability".
This is Part 4a of a series covering the major branches of cannabinoids. Parts 1 to 3 covered the other major branches; Part 1 - CBG-a, The Precursor, and CBG. Part 2 covered Cannabidiols (CBD's) including Cannabidiolic acid (CBD-a). Part 3 covered Cannabichromenes (CBC's), including Cannabichromenic acid (CBC-a). Parts 4b and 4c will cover Tetrahydrocannabinolic acid (THC-a) along with Delta-8-Tetrahydrocannabinol, Cannabinolic-acid (CBN-a) and Cannabinol (CBN).
Resources;
What is THC?, 7 Proven Medical Benefits of THC, How do THC, CBD, CBN Relate to Marijuana Potency?, Cannabinoids - Learn, No Official Lethal Dose For Cannabis, Safety Profile of Medical Cannabis - NORML, Cannabis and Crohn's, The Case For Medical Marijuana In Epilepsy, Is Marijuana an Effective Treatment for Glaucoma?, Using Cannabis to Treat Glaucoma, Marijuana Could Help Treat MS, Cannabis Treats PTSD Symptoms - Pilot Study, 60 Peer Reviewed Studies on Medical Marijuana and Granny Storm Crow's List 2015